Boots
This coverage focuses on Boots’ operations and strategy within the UK retail and pharmacy landscape. Reporting highlights store developments, financial performance, leadership changes, healthcare initiatives, and marketing campaigns. With analysis of how Boots balances retail and health services, the insights support managers and executives evaluating its market position and strategic direction.
-
Jul- 2025 -7 JulyClothing & Shoes
H&M latest retailer to trial staff body cameras
H&M has started trialling body-worn cameras for its staff in the UK as retailers seek to address rising levels of theft and violence in stores. According to This is Money, the Swedish fashion retailer is testing the equipment at branches in Edinburgh, Wood Green and Beckton in London. It follows…
Read More » -
Jun- 2025 -27 JuneHealth & Beauty
Boots sales rise 5% in Q3 amid strong online performance
Walgreen Boots Alliance has reported that its International segment saw sales rise by 7.8% to $6.2bn (£4.5bn) during the third quarter, with Boots UK sales growing 5% and the Germany wholesale business growing 6.8%. The group, which is the parent company of Boots, has seen its third quarter sales rise…
Read More » -
May- 2025 -12 MayHigh Street
Boots chair to hike stake to 50% following $10bn takeover deal
The chairman of Boots is reportedly set to hike his stake in Walgreens Boots Alliance to almost 50% as part of the group’s $10bn (£7.5bn) takeover deal, The Times has reported. While chair Stefano Pessina, who previously held a 17% stake in the Anglo-American group, will put in more money…
Read More » -
8 MayHigh Street
Mothercare retail sales fall 18% in FY25
Mothercare, the specialist global brand for parents and young children, has reported an 18% decline in its worldwide retail sales by franchise partners of £231m (FY24: £281m) for the 52 week period to 29 March 2025 (FY25). According to the group, the decline largely resulted from the unchanged trading conditions…
Read More » -
Apr- 2025 -23 AprilFeatures
The potential ripple effect of Asda’s Rollback return
Asda has brought back its “iconic” Rollback scheme, reducing prices on more than 4,000 products in stores and online. As a result, more than £4bn has been wiped off the value of Tesco, Sainsbury’s and Marks and Spencer stock amid fears that rival Asda will step up the grocery price…
Read More » -
9 AprilHealth & Beauty
Boots UK sales see 1.6% uptick in Q2
Boots UK sales have risen by 1.6% in the second quarter of trading, as owner Walgreens Boots Alliance saw Q2 sales rise 4.1% year-on-year to $38.6bn (£30bn).Boots UK comparable retail sales rose by 5.1% against the prior year, with growth reported across all categories. Elsewhere, comparable pharmacy sales increased 5%…
Read More » -
3 AprilFeatures
Is going private the next big trend in retail?
Walgreens Boots Alliance was acquired by the American private equity firm Sycamore Partners in a deal valued at up to $23.7bn (£18.3 billion). Around the same time, Pepco Group, owner of Poundland, received interest from potential buyers for its 825-store Poundland business in the UK. With major retailers opting for…
Read More » -
Mar- 2025 -7 MarchNews-In-Brief
Today’s news in brief-7/3/25
Walgreens Boots Alliance (WBA) has agreed to be acquired by private equity firm Sycamore Partners in a deal worth £23.7bn. The transaction is expected to close in late 2025 and will see WBA become a private company, delisting from Nasdaq.WBA shareholders will receive $11.45 per share in cash, with potential…
Read More » -
7 MarchHigh Street
Boots owner sold to Sycamore Partners in $23.7bn deal
Walgreens Boots Alliance has announced that it has been acquired by American private equity firm Sycamore Partners in a deal worth up to $23.7bn (£18.3bn). The transaction is expected to close in the fourth quarter calendar year 2025, subject to customary closing conditions, including approval by WBA shareholders and the…
Read More » -
5 MarchNews-In-Brief
Today’s news in brief-5/3/25
Walgreens Boots Alliance, owner of Boots, is in advanced talks with private-equity firm Sycamore Partners for a potential $10 billion deal to take the struggling drugstore chain private. This move comes amid Walgreens’ shares declining sharply over the past decade, from a peak market value of over $100bn in 2015…
Read More »
